Search results

Order by most recent / most popular / relevance

Results: 1-3 of 3

Comparative advertising of a generic medicine

Bird & Bird
-
France
-
December 15 2009

It is not necessary within the meaning of Article L. 713-6 of the French Intellectual Property Code (“CPI”) to mention the brand of the reference product in comparative advertising for a generic medicine, as the healthcare professionals to which the advertising is directed have other means (namely, the INN - international non-proprietary name) by which to identify the corresponding reference product

Awaited judgment from the ECJ on dissemination of information by an independent third party - it may be regarded as advertising

Bird & Bird
-
European Union
-
July 17 2009

On 2 April 2009 the ECJ interpreted Article 86 of Directive 200183EC definition of advertising for medicinal products

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

Bird & Bird
-
Sweden
-
May 22 2013

This article is a follow-up to an article in our March 2012 update concerning the decision of the Swedish Medical Products Agency (the "MPA"

Search results

Comparative advertising of a generic medicine

Awaited judgment from the ECJ on dissemination of information by an independent third party - it may be regarded as advertising

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

Current Search

Suggested Facets

Author

Jurisdiction